Organigram: Mixed Commentary From Analysts Following Q1 2021 Results
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) yesterday morning reported its first-quarter 2021 financial results for the period ended November 30,
Read moreOrganigram Holdings (TSX: OGI) (NASDAQ: OGI) yesterday morning reported its first-quarter 2021 financial results for the period ended November 30,
Read moreOrganigram Holdings (TSX: OGI) (NASDAQ: OGI) this morning reported its first quarter 2021 financial results for the period ended November
Read moreYesterday, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) reported their fourth quarter financials. The company announced net revenues of $20.4 million,
Read moreOrganigram Holdings (TSX: OGI) (NASDAQ: OGI) this morning reported its fourth quarter financials, with net revenues of $20.4 million and
Read moreOn Friday, Raymond James reiterated Organigram Holdings (TSX: OGI) (NASDAQ: OGI)‘ market perform rating while downgrading their 12-month price target
Read moreIn response to the spread of COVID-19, the Canadian Federal Government introduced several programs to try and alleviate the economic
Read moreOrganigram Holdings (TSX: OGI) (NASDAQ: OGI) is the latest cannabis operator to raise funds. The company announced this morning that
Read moreRecently, Cantor Fitzgerald released their monthly review of Hifyre data for the four weeks ending September 19th. In the summary,
Read moreYesterday, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) released its financial statements for the third quarter of 2020. The company reported
Read moreRevenue at Organigram Holdings (TSX: OGI) (NASDAQ: OGI) continues to fall. The company this morning reported net revenue of $18.0
Read more